Not applicableUnknownNCT04391400
What this trial is testing
The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines
Who this might be right for
SARS-CoV-2
Invivoscribe, Inc. 500